A short history of anti-rheumatic therapy. I. An introduction on traditional and drug treatments

被引:1
|
作者
Pasero, G. [1 ]
Marson, P. [2 ]
机构
[1] Univ Pisa, Pisa, Italy
[2] Univ Padua, Azienda Osped, UOC Immunotrasfus, Unita Aferesi Terapeut, Padua, Italy
关键词
History of medicine; rheumatology; traditional treatments; drugs; spa therapy; physical therapy;
D O I
10.4081/reumatismo.2010.76
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The origins of anti-rheumatic therapy are very old and mainly related to the use of traditional, sometimes extravagant, treatments, as a part of folk medicine. Spa therapy has long been used for the treatment of rheumatic diseases, as well as, in later times, physical treatments, including electrotherapy. Drug treatment has developed beginning from substances of vegetable origin, such as willow and colchicum extracts. Then it has been spread out through the chemical synthesis of compounds with specific action and therefore more effective, owing to the great development of pharmaceutical industry.
引用
收藏
页码:76 / 83
页数:8
相关论文
共 50 条
  • [41] Addition of leflunomid therapy to the active rheumatuid arthritis patients, who had been treated with three-disease modifying anti-rheumatic drug (DMARD) combination therapy: A preliminary report of the short term adverse effects
    Caiguneri, M
    Apras, S
    Ozbalkan, Z
    Ertenli, I
    Kiraz, S
    Ozturk, MA
    Akdogan, A
    Ureten, K
    Onat, A
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 408 - 409
  • [42] Association Between Changes in Pain Sensitization and Changes in Disease Activity After 12 Weeks of Disease Modifying Anti-Rheumatic Drug Therapy in Rheumatoid Arthritis
    Heisler, Andrew
    Song, Jing
    Muhammad, Lutfiyya
    Wohlfahrt, Alyssa
    Marder, Wendy
    Bolster, Marcy
    Bingham, Clifton, III
    Clauw, Daniel
    Dunlop, Dorothy
    Neogi, Tuhina
    Lee, Yvonne
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [43] PHONE FOLLOW-UP PROGRAM ENHANCES TREATMENT SAFETY AND DRUG CONCORDANCE ON DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS) THERAPY FOR RHEUMATOLOGY PATIENTS
    Lee, P. F.
    Cheung, Y. S.
    Lam, C. K.
    Leung, M. C.
    Chan, C. M.
    Ng, W. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1493 - 1494
  • [44] Disease-modifying anti-rheumatic drugs are only one of a number of potential causes of myelosuppression: a careful drug history is necessary to elucidate the cause of an adverse event
    Marshall, RW
    Marshall, VJ
    Hull, R
    RHEUMATOLOGY, 2006, 45 (03) : 362 - 363
  • [45] Timing of Decisions to Adjust Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy for Rheumatoid Arthritis (RA) Patients with Active Disease in a Usual Practice Setting.
    Shaw, Yomei
    Chang, Chung-Chou H.
    Levesque, Marc C.
    Donohue, Julie M.
    Michaud, Kaleb
    Roberts, Mark S.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S640 - S640
  • [46] Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA)
    Singh, Jasvinder A.
    Hossain, Alomgir
    Ghogomu, Elizabeth Tanjong
    Mudano, Amy S.
    Tugwella, Peter
    Wellsb, George A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (11):
  • [47] TOFACITINIB VERSUS BIOLOGIC TREATMENTS WITH AND WITHOUT METHOTREXATE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS WHO HAVE HAD AN INADEQUATE RESPONSE TO TRADITIONAL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS - A NETWORK META-ANALYSIS
    Vieira, M. G.
    Wallenstein, G. V.
    Bradley, J. D.
    Gruben, D.
    Koncz, T.
    Zwillich, S. H.
    Jansen, J. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 375 - 375
  • [48] Patterns of Use and Predictors of Initial Disease-Modifying Anti-Rheumatic Drug Therapy in Early Rheumatoid Arthritis: Results From a Multicenter Canadian Early Arthritis Cohort
    Hazlewood, Glen
    Akhavan, Pooneh
    Sun, Ye
    Boire, Gilles
    Haraoui, Boulos
    Hitchon, Carol
    Keystone, Edward
    Thorne, Carter
    Ferland, Diane
    Pope, Janet
    Bykerk, Vivian
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1730 - 1731
  • [49] Micro-structural bone changes in early rheumatoid arthritis persist over 1-year despite use of disease modifying anti-rheumatic drug therapy
    Feehan, Lynne M.
    Li, Linda L.
    McKay, Heather A.
    BMC MUSCULOSKELETAL DISORDERS, 2017, 18
  • [50] COVID-19 vaccination in patients on biologic or targeted-synthetic disease modifying anti-rheumatic drug therapy: A multi center real-world data
    Yildirim, Tuba Demirci
    Akleylek, Cansu
    Yildirim, Derya
    Cinakli, Haluk
    Hakbilen, Selda
    Coskun, Belkis Nihan
    Okyar, Burak
    Isik, Ozlem Ozdemir
    Sagir, Rabia Piskin
    Apaydin, Hakan
    Karakas, Ali
    Erez, Yesim
    Inel, Tuba Yuce
    Gulle, Semih
    Tufan, Abdurrahman
    Akar, Servet
    Yilmaz, Sema
    Yilmaz, Neslihan
    Pehlivan, Yavuz
    Cetin, Gozde Yildirim
    Cefle, Ayse
    Koca, Suleyman Serdar
    Erten, Sukran
    Dalkilic, Ediz
    Yazici, Ayten
    Sen, Gercek
    Sari, Ismail
    Birlik, Ahmet Merih
    Onen, Fatos
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2025, 18 (02) : 77 - 83